Richtig G, Wolf M, Schulter G, et al. Body-Mass-Index as a predictive marker for response in patients with metastatic melanoma treated with ipilimumab. SMR 2017, P01-15.
Grote globale verschillen in implementatie van hypofractionering bij radiotherapie
nov 2018 | Borstkanker, Radiotherapie, Uro-oncologie